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[57] ABSTRACT 
Plants that accumulate the yeast polyadenylate binding 
protein (yPAB) display a range of abnormalities, including 
a characteristic chlorosis in leaves to a necrosis and pro 
nounced inhibition of groWth. The severity of these abnor 
malities re?ects the levels of yeast PAB expression in the 
transgenic plants. In contrast, no obvious differences are 
seen in undifferentiated callus cultures that express the same 
range of yeast PAB. The expression of the yeast PAB1 gene 
in plants does not affect expression of the plant PAB gene 
family or alter poly(A) length in the total RNA population. 
It is proposed that the yeast PAB1 gene or its product 
interferes With as yet unidenti?ed functions of PABs, Which 
functions are manifest only in differentiated, developed 
plants. Surprisingly, transgenic plants expressing the yeast 
PAB1 gene are also observed to have a systemic acquired 
resistance (SAR) to bacterial, fungal and viral pathogens. 
20 Claims, 5 Drawing Sheets 
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USE OF YEAST POLY (A) BINDING 
PROTEINS AND THEIR GENES FOR BROAD 
RANGE PROTECTION OF PLANTS 
AGAINST BACTERIAL, FUNGAL AND 
VIRAL PATHOGENS 
STATEMENT OF GOVERNMENT SUPPORT 
The present invention Was developed in part With support 
received from a US. Department of Agriculture— 
University of Kentucky Cooperative Agreement (#58 
43YK-7-0025) and USDA Grant #89-37262-4835. The 
Government may have certain rights in the invention. 
TECHNICAL FIELD 
The present invention is related to the ?eld of transgenic 
plants. Among the observed phenotypes of the transgenic 
plants is a systemic acquired resistance (SAR) to bacterial, 
fungal and viral pathogens. 
BACKGROUND OF THE INVENTION 
Polyadenylate binding proteins (PABs) play important 
roles in gene expression. In yeast, they are involved in 
recruitment of large ribosomal subunits to form the transla 
tion initiation complex (1), and for the progressive shorten 
ing of polyadenylate tracts on cytoplasmic mRNAs PABs als  play important roles in gene expression in plants. 
In particular, they presumably mediate the poly(A)-cap 
synergism that is required for optimal translation of mRNAs 
in plant cells 
PABs are highly conserved RNA-binding proteins that 
speci?cally bind the 3‘ polyadenylate tracts of cytoplasmic 
mRNAs. PABs from different organisms have a common 
region in the N-terminal tWo-thirds of the protein that 
consists of four repeating RNA-binding domains of 80 to 90 
amino acid residues Each domain contains tWo con 
served motifs (the so-called RNP-1 and RNP-2 motifs; 4,5). 
There is also a conserved domain in the C-terminal regions 
of PABs (6), a domain separated from the RNA binding 
domains by a variable spacer region. It has been suggested 
that the N-terminal region determines poly(A)-binding 
activity and the C-terminal region mediates interactions 
betWeen PABs and other proteins (3,6,7). 
To date, most Work With plant PABs has focused on the 
characteriZations of puri?ed proteins and clones for PABs. 
SieliWanoWicZ (8) described a protein in pea extracts that 
bound poly(A)-Sepharose and Was able to stimulate trans 
lation in a cell-free system. Yang and Hunt (9) previously 
described the puri?cation and characteriZation of a 70 kD 
PAB from the leaves of young pea seedlings. This protein 
Was similar to pea PAB described by SieliWanoWicZ (8) and 
had RNA binding properties similar to those of PABs from 
other organisms. Three Arabidopsis PAB genes have been 
isolated and characteriZed (6,10). One Arabidopsis gene 
codes for a protein With extensive similarity to PABs from 
other organisms but is novel in that it is expressed only in 
?oWers (10). Another Arabidopsis PAB gene is expressed in 
root and shoot tissues (6), suggesting that different forms of 
PAB may exist in different tissues in plants. Gallie (2) 
inferred a positive role for plant PABs in translation, based 
on the increased translatability of polyadenylated RNAs in 
isolated tobacco protoplasts. These studies also suggested a 
link betWeen the presence of a 5‘ cap and a 3‘ polyadenylate 
tract in an RNA, as a 5‘ cap Was needed for the enhanced 
translatability provided by a 3‘ polyadenylate tract. This 
feature Was not unique to plant cells, as it Was also observed 
in Chinese hamster ovary and yeast cells 
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As described herein, a yeast PAB gene is expressed in a 
plant, e. g., the yeast PAB1 gene in tobacco. The utility of this 
gene as a potential trans-dominant marker to probe PAB 
function in plants can then be assessed. A cDNA encoding 
a Wheat PAB protein has been transformed in yeast, Where 
it Was observed to functionally complement a PAB1 mutant 
yeast, suggesting that this monocot protein can function in 
yeast (25). Apparently, hoWever, the reverse approach, trans 
forming a differentiated higher plant With a yeast PAB gene, 
has not previously been explored. 
SUMMARY OF THE INVENTION 
It has noW been observed that transformed plants, Which 
express the yeast PAB1 gene, are impaired in groWth and 
development. The severity of the observed impairment cor 
responds to the quantity of yeast PAB (yPAB) seen in the 
transgenic plants, and is not caused by a cosuppression of 
expression of the endogenous tobacco PAB genes. 
Interestingly, the groWth impairment is seen in regenerated 
plants, but not in plant cell cultures. At a minimum, these 
observations suggest that the yeast PAB1 gene should be a 
useful tool for the further characteriZation of plant mRNA 
translation and metabolism. 
It is also observed that the resistance of a plant to a 
bacterial, fungal or viral pathogen is enhanced When the 
plant is transformed With a yeast PAB1 gene or its encoded 
product. Thus, a method of enhancing the pathogen resis 
tance of a plant comprises transforming it With a polynucle 
otide that encodes a yPAB protein, and maintaining the 
transformed plant under conditions effective to express the 
yPAB protein. In a preferred embodiment, an aforemen 
tioned polynucleotide encodes the yeast PAB1 protein. 
Although the precise mode(s) by Which a yPAB gene or 
protein is effective in enhancing pathogen resistance is 
presently unclear, it is believed that the RNA-binding ability 
of the PAB1 protein plays a central role in imparting such 
resistance perhaps by interfering With one or more “normal” 
cellular processes, Which trigger local defense responses and 
eventually systemic acquired resistance Thus, it is 
likely that plants transformed With a yPAB coding sequence 
according to the present invention can be protected from 
infections by a Wide range of normally compatible bacterial, 
fungal and viral pathogens. 
A preferred aspect of the present invention entails pro 
viding a self-regulatory function to expression of the yPAB 
protein in the transgenic plant so that pathogen resistance is 
achieved Without adversely affecting groWth of the plant. 
One means of achieving such self-regulation is by linking a 
lac repressor gene to a pathogen resistance (PR) promoter in 
a suitable vector, e.g., a pKYLX7 vector. Transgenic plants 
carrying such an assembly of regulatory elements can 
express the yPAB protein to levels that trigger defense 
responses, Which in turn cause lac repressor to accumulate 
and suppress further expression of yPAB protein. A “con 
stitutive” SAR to pathogens is thereby induced Without 
substantially compromising the groWth of neW leaves. 
BRIEF DESCRIPTION OF THE FIGURES 
FIG. 1 shoWs the structure of the chimeric gene contain 
ing the yeast PAB1 gene and its position in the micro-T 
DNA present in pKYLX71:35S2. The promoter present in 
this plasmid is a modi?ed cauli?oWer mosaic virus 35S 
promoter that contains a duplication of the enhancer region; 
it has been described in detail elseWhere (13). 
FIG. 2 depicts phenotypes of plants that express the yeast 
PAB1 gene. Primary transformants representative of plants 
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regenerated from callus lines F6 (plant A), All (plant B), E2 
(plant C), and a transformed control line (plant D) are 
shoWn. 
FIG. 3 illustrates the appearances of leaves from plants 
that express the yeast PAB1 gene. The leaf on the left Was 
from an All plant (severe impairment), the center leaf Was 
from an E2 plant (mild impairment), and the leaf on the right 
from a transformed control. 
FIGS. 4A and 4B shoW that the A11 line is resistant to a 
bacterial and a viral pathogen. Transformed control plants 
(right) and F1 individuals derived from line All (left; see 
FIG. 2) Were inoculated With TMV (A) or R syringe pv 
tabaci WF4 The series of spots seen in the controls 
represent a series of dilutions of each pathogen. For TMV, 
the concentrations Were, from top to bottom, 0.5, 0.1, 0.02 
mg/mL. The spot on the bottom is a Water control. In the R 
syringe pv tabaci WF4 test, 200,000 and 20,000 cfu/mL 
Were inoculated on right and the left hand side of the leaf, 
respectively. The bottom sample Was Water control. 
FIG. 5 shoWs the results of WF4 population counts for 
line All and transformed control GB1B. For bacterial 
population studies, 20,000 times dilution Was used. After 
in?ltration of the WF4 on the tobacco leaf (7 to 8 Weeks old 
plants, 3 plants each line), the in?ltrated area Was marked for 
easier sampling. TWo leaf discs (diameter=6 mm) Were taken 
from each in?ltrated area, Washed by 70% ethanol for tWo 
minutes, rinsed With Water 3 times. Then each leaf disc Was 
ground in 100 mL sterile Water, and spun brie?y. The 
supernatant Was diluted and spread on LB agar plate for 
colony counting, after 2 days culture at 30° C. Leaf samples 
Were taken daily from day 0 to day 6. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention concerns a method of providing or 
enhancing resistance of a plant to a bacterial, fungal or viral 
pathogen. The method comprises transforming the plant 
With a polynucleotide encoding a yeast polyadenylate bind 
ing protein (yPAB), and maintaining the plant under condi 
tions effective to express the yPAB. 
The plant is transformed using a method suited for the 
particular species. Many different protocols are available, 
for instance, by transforming callus cultures or leaf explants. 
Preferably, the transformation is performed using an Agro 
bacterium vector that encodes the yPAB. 
In a preferred embodiment, a polynucleotide encoding a 
yPAB is one that encodes a yeast PAB1 protein. 
Accordingly, the polynucleotide preferably includes a cod 
ing sequence of the yeast PAB1 gene. The coding sequence 
can be obtained by direct synthetic techniques, restriction 
excision of genomic material, excision of extrachromosomal 
DNA material containing the gene, or by generation of 
cDNA from mRNA encoding the yPAB1 protein. Conven 
tional genetic engineering techniques such as those set forth 
in Sambrook J. et al., Molecular Cloning, 2nd ed., can be 
employed. 
An expression vector in Which the polynucleotide encod 
ing a yPAB protein is provided is additionally provided With 
the regulatory domains necessary to effect transcription of 
the yPAB-encoding polynucleotide. One feature of such a 
regulatory domain is the promoter sequence, Which is typi 
cally provided upstream of the yPAB-encoding sequence 
and is operably linked thereto. A CaMV promoter, such as 
the 35S2 promoter containing a double enhancer region, is 
preferred. The expression vector can be in the form of a 
linear or circulariZed plasmid or as a virus, Which contains 
the nucleic acids either as DNA or complementary RNA. 
10 
15 
20 
25 
30 
35 
40 
45 
55 
60 
65 
4 
In order to avoid deleterious over-expression of the yPAB 
protein, Which can cause excessive stunting of groWth, it is 
desired to “feedback” the level of expression to the regula 
tory elements controlling transcription. For instance, a yeast 
PAB1 encoding sequence can be operably linked to a CaMV 
35S promoter into Which one or more lac operator sequences 
have been inserted. The positions of these sequences can be 
optimiZed for repression of yPAB1 expression in the pres 
ence of the lac repressor. In addition, the lac repressor (lacI) 
gene can be linked to a PR (pathogen resistance) gene 
promoter using standard techniques and cloning strategies. 
Plants transformed With these elements, e.g., as part of an 
expression vector, can express the PAB1 protein, thereby 
inducing a defense response. Expression of the lad gene 
can, in turn, be induced since it is under the control of the 
PR promoter. Once lac repressor accumulates, further 
expression of the PAB1 gene can be suppressed, thereby 
eliminating the harmful effects of expression of these genes. 
Initial or exploratory studies can be performed on tobacco 
using pKYLX7 as a “base vector.” Protocols and vectors 
employing the lac operator/promoter are described herein 
and by Sambrook et al. The PR promoter and its use in a 
cloning vehicle are described herein and previously (24). 
A plant host targeted With an expression vector of the 
present invention is one effectively transformed With a 
yPAB-encoding polynucleotide. The plant host is typically a 
monocot or dicot, and includes corn, rice, Wheat, maiZe, 
alfalfa, oats, barley, rye, sorghum, clover, tobacco, tomato, 
pea, potato, cauli?oWer, beans, cucumber, beet, turnip, 
spinach, kale, cabbage, squash, melon, cotton, apple, peach, 
plum, among others. Of course, the plant need not be in its 
adult differentiated state. Seeds, gern lines, leaf explants, 
and callus cultures transformed With nucleic acids encoding 
a yeast PAB protein are also contemplated. The induced 
SAR can cause the plant to shoW resistance to subsequent 
infection by a Wide range of normally compatible pathogens 
(27). 
Representative plant bacterial pathogens, for Which a 
transformed plant can be provided With enhanced resistance, 
are listed in Table 1 by genus and associated disease. 
Representative groups of fungal pathogens of plants, to 
Which a plant transformed according to the principles of the 
present invention can be provided With enhanced resistance, 
include Ascomycetes, Basidiomycetes, Zygomycetes, 
Oomycetes, Deuteromycetes, Peronosporomycetes, 
Chytridiomycota, Zygomycota, Plectomycetes, 
Loculoascomycetes, Discomycetes, Pyrenomycetes, 
Heterobasidiomycetes, Homobasidiomycetes, Teliomycetes, 
Ustomycetes, Septomycetes, Saprolegniomycetidae, and 
Plasmodiophorida, and the like. 
Representative plant viruses that a transformed host can 
shoW enhanced resistance against include those listed in 
Table 2. Particularly preferred, at least for further explor 
atory studies, is tobacco mosaic virus (TMV). Cytoplasmic 
plant viruses, i.e., those for Which the viral nucleic acids 
remain extrachromosomal folloWing infection, are expected 
to be especially susceptible to inhibition With a yPAB due to 
their presence in the cytosol. 
Whenever the plant is transformed as described herein 
and the transformation is stably maintained by the organism, 
the pathogen resistance trait of the yPAB is inheritable. 
Coincident With acquiring the pathogen resistance is acti 
vation of a pathogen resistance (PR) gene of the plant. As 
noted above, this aspect of pathogen response can be 
employed to provide a self-regulatory function to expression 
of a yPAB protein. In particular, plants can be obtained that 
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have one older leaf (or sector thereof) that contains detect 
able expression of yPAB protein, While younger leaves 
contain no yPAB protein due to suppression of transcription 
of the nucleotide sequence encoding this protein. HoWever, 
the younger leaves are resistant to a broad range of patho 
gens due to induction of the “constitutive” SAR upon 
expression of yPAB in the older leaf. 
A related aspect of the present invention is a plant 
transformed With a polynucleotide encoding a yeast PAB 
protein. Thus, the plant preferably is transformed With a 
polynucleotide that includes a yPAB encoding sequence. As 
demonstrated herein, a yeast PAB1 encoding sequence can 
be operably linked to a 35S2 promoter for ef?cient transcrip 
tion. Aplant so transformed has an enhanced resistance to a 
bacterial, fungal or viral pathogen relative to the resistance 
of a plant not transformed With such a polynucleotide. A 
preferred expression vector is Agrobacterium containing an 
insert of the aforementioned polynucleotide. 
For purposes of clarity and understanding, the invention 
Will noW be illustrated by certain examples, but is not 
limited by these examples. 
EXAMPLES 
Example 1 
Recombinant DNA Manipulations 
Recombinant DNA manipulations, PCR reactions, and 
DNA sequencing Were carried out using standard protocols 
(15,16). To clone the yeast PAB1 gene for expression in 
plants, the folloWing oligonucleotide primers Were used: 
5‘ . TTCTCGAGACCATGGCTGA 
TATTACTGATAAG . . . 3‘ (SEQ ID NO: 1) 
5 ‘ . . 
TTGAGCTCTTAAGCTTGCTCAGTTTGT-TG . . . 3‘ 
(SEQ ID NO: 2). 
The yeast PAB1 gene Was ampli?ed by PCR using 35 
cycles consisting of 1 min at 92° C., 1 min at 55° C., and 2 
min at 72° C. The resulting oligos Were subcloned into 
pBluescript (Stratagene, La Jolla, Calif.) to con?rm their 
sequence and then the PAB1 gene Was cloned as an NcoI 
SstI fragment into the plant expression vector pKYLX71 
35S2 (11). 
Example 2 
Plant Transformations and Callus Cultures 
Recombinant expression plasmids Were transferred into 
Agrobacterium tumefaciens C58C1::pGV3850 (17) by tri 
parental mating (18) and transconjugant Agrobacteria used 
to transform tobacco. For this, sterile leaf disks (12) Were 
incubated With Agrobacterium suspensions (in Luria broth 
[15]; ca. 109 cells/mL) for 5—15 min, then transferred to MS 
agar media (19) containing 3% sucrose, 2.5 mg/L benZy 
laminopurine (BA), and 1 mg/L indole-3-acetic acid After 2—3 days on this media, leaf explants Were transferred 
to the same media supplemented With 300 mg/L kanamycin 
and 500 mg/L Mefoxin (Merck, Sharpe, and Dohme, 
RahWay, N.J.); these explants, and the resulting callus 
cultures, Were transferred to fresh media 1—2 times per 
Week. Regenerating shoots Were transferred to rooting 
media (MS agar containing 3% sucrose and 500 mg/L 
Mefoxin); rooted plants Were then transferred to soil and 
maintained in the greenhouse. In some instances, callus 
cultures Were maintained for several months on MS agar 
media containing 3% sucrose, 2.5 mg/L benZylaminopurine 
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(BA), 1 mg/L indole-3-acetic acid (IAA), 300 mg/L 
kanamycin, and 500 mg/L Mefoxin. 
Example 3 
Protein Extraction 
Denatured tissue extracts Were prepared for immunoblot 
analysis to minimize protein degradation. For this purpose, 
300 mg of leaf tissue Was collected from comparably aged 
leaves of young plantlets (4—6 leaf stage); this Was necessary 
to permit sampling of leaves that Were laregly devoid of 
necrotic areas. Leaf tissue Was homogeniZed in 200 pL of 
2><SDS-PAGE sample buffer (0.125 M Tris HCl, pH 6.8, 
20% [v/v] glycerol, 2% [W/v] SDS, 10% [v/v] 
b-mercaptoethanol, and 0.001% [W/v] bromphenol blue) and 
boiled for 10 min. After a brief centrifugation, cell debris 
Was discarded and the supernatant Was stored at —20° C. 
To prepare non-denatured extracts for 
immunoprecipitations, betWeen 1 and 2 g of leaf tissue from 
an appropriate plant Was ground homogeniZed in 4 mL/g of 
Buffer A (100 mM KCl, 30 mM Tris-HCl, pH 8.0, 1 mM 
CaCl2, 1 mM MgCl2, 5 mM EDTA, 5 mM phenylmethyl 
sulfonyl ?uoride [PMSF], 15 mM [3-mercaptoethanol, and 
1.5 pg/mL each of leupeptin, chymostatin and antipain) 
using a mortar and pestle. Cell debris Was removed by 
centrifugation and the supernatant stored at —20° C. The 
preparation Was done at 0 to 4° C. 
Example 4 
Immunoblot Analysis 
For immunoblots, the protein from 30 mg of leaf tissue 
Was separated by SDS-PAGE and the separated proteins 
transferred to a nitrocellulose membrane (20) using a Trans 
Blot Cell (Bio-Rad Laboratories, Richmond, Calif.) folloW 
ing the manufacturer’s recommendations. Filters Were 
probed With monoclonal antibodies speci?c for the yeast 
PAB (provided by Dr. Maurice SWanson, University of 
Florida) or polyclonal antibodies raised against the puri?ed 
pea PAB (21). Brie?y, ?lters containing transferred proteins 
Were incubated (at room temperature) in TTBS (20 mM 
Tris-HCl, pH 7.5, 0.5 M NaCl, 0.05% [v/v] TWeen 20) for 
5 min, TTBS containing 5% (W/v) nonfat dried milk for 1 hr, 
and then With 5% milk-TTBS containing a 1:1000 dilution 
of antibody for 12—16 hr. The monoclonal antibody Was 
removed With three Washes (5 min each) of TTBS, the ?lters 
incubated for 3 hr With 5% milk-TTBS containing goat 
anti-mouse IgG alkaline phosphatase conjugate (for blots 
probed With the anti-yeast PAB) or goat anti-rabbit IgG 
alkaline phosphatase conjugate (for blots probed With the 
anti-pea PAB; Sigma), and this antibody conjugate removed 
With three Washes of TTBS. Filters Were equilibrated in AP 
buffer (0.1 M Tris-HCl, pH 9.5, 0.1 M NaCl, 0.05 M MgCl2) 
and developed inAP buffer+2 mg/mL nitroblue tetraZolium+ 
1.2 mg/mL 5-bromo-4-chloro-3-indoyl phosphate; develop 
ment Was stopped by Washing With deioniZed Water. 
Example 5 
Immunoprecipitations 
PABs Were immunoprecipitated from non-denatured pro 
tein extracts (see above) as folloWs. 650 mg of protein (in 
volumes ranging from 0.24 to 0.50 mL) Were incubated With 
2.5 mL of antibody (estimated protein content of 0.4 
mg/mL) and incubated on ice for 4 hr With shaking. 25 mL 
of Protein A-agarose (Sigma Chemical Co., St. Louis, Mo.) 
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Was then added and the suspension incubated for 30 min on 
ice. The Protein A-agarose Was then collected by centrifu 
gation (30 sec. in a microcentrifuge), Washed three times 
With 400 ML PAB Buffer A, resuspended in 100 pL of 
2><SDS-PAGE sample buffer, and boiled for 10 min. 25 pL 
Were analyzed by SDS-PAGE and staining With Coomassie 
Brilliant Blue (15). PAB contents on these gels Were esti 
mated by comparison With standards and With the IgG 
bands. 
Example 6 
Poly(A) Length Determinations 
RNA Was isolated from single primary transformants by 
homogeniZing leaf tissue in a guanidinium thiocyanate 
buffer (22) and pelleting through a cesium chloride gradient 
(23). To determine poly(A) lengths, 50 mg of total RNA 
from each plant line Was precipitated With ethanol, dried 
under vacuum, and dissolved in 10 mL of Water. To this Was 
added 4 mL of 5><yeast PAP reaction buffer (U.S. 
Biochemicals, Cleveland Ohio) and 5 mL of [a-32P]3‘-dATP 
(about 1 mCi/mL in 1><yeast PAP reaction buffer, 3000—5000 
Ci/mmol). One mL (300 units) of yeast PAP (U.S. 
Biochemicals) Was added and the labeling mixture incubated 
at 30° C. for 1 hr. This mixture Was then placed at 70° C. for 
5 min and placed on ice. 100 ng of RNAse A (Boehringer 
Mannheim, Indianapolis, Ind.) Was added and the mixtures 
incubated at 37° C. for 1 hr. The sample Was then diluted 
With 100 mL of TE (10 mM Tris HCl, pH 8.0, 1 mM EDTA) 
and extracted once With phenol/chloroform/isoamyl alcohol 
(25 :24:1), once With chloroform, precipitated, dried, and 
analyZed by electrophoresis on 6% sequencing gels. Labeled 
poly(A) tracts Were visualiZed by autoradiography. 
Example 7 
Bacterial Resistance Test 
The tobacco bacterial pathogen Pseudomonos syringe pv. 
tabaci Wild ?re 4 (WF4, kindly provided by Dr. Sheng-Yang 
He, Michigan State University) Was cultured in LB media at 
30° C. An overnight culture Was pelleted by centrifugation 
and resuspended in Water to an OD600 of 1.0. 20,000 and 
200,000 fold dilutions Were prepared from this suspension 
and used as inocula. Water Was used as control in all 
experiments. These various inocula Were applied to the 
undersides of selected leaves of 7—8 Week old plants using 
a 1 mL syringe; suf?cient inoculum to form a 10 mm 
diameter circle at the site of inoculation Was applied. After 
5—6 days of groWth (betWeen 22° C. and 25° C., With a 12/12 
light/dark cycle), the inoculated leaves Were removed and 
photographed. 
To study the groWth of WF4, leaves of three plants (in 
identical positions, and lacking noticeable PABL1-related 
“symptoms”) Were inoculated With the 1/20,000 dilution as 
described in the preceding section. After inoculation of the 
WF4 on the tobacco leaf, the in?ltrated area Was marked for 
easier sampling. At different times over the course of 6 days, 
tWo leaf discs (6 mm diameter) Were taken from each 
in?ltrated area, Washed With 70% ethanol for tWo minutes, 
and rinsed With Water 3 times. Each leaf disc Was then 
ground in 100 mL sterile Water and spun brie?y. The 
supernatant Was then diluted and spread on LB agar plate for 
colony counting. 
Example 8 
TMV resistance test 
Tobacco mosaic virus (TMV, kindly provided by Dr. Wu, 
Department of Plant Pathology, University of Kentucky) 
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Was inoculated to leaves of 7—8 Week old plants (6 duplicates 
per line). For this, serial dilutions of a TMV stock Were made 
(yielding ?nal virus concentrations of 0.5, 0.1 and 0.02 
mg/mL, respectively) and 10 mL of each Was applied to a 
leaf surface that had been previously treated With carborun 
dum. Mock inoculations Were done With Water instead of 
diluted virus. After 7 days, inoculated leaves Were removed 
and photographed. 
Example 9 
Reduction of Fungal Spore Production by 
Transgenic Tobacco Cell Lines 
The effects of transformation of tobacco plants on spore 
production by the blue mold fungus Peronospora tabacina 
Adam Was studied. In these studies R tabacina Adam 
(obtained in Kentucky in 1979 and designated isolate 79) 
Was maintained by Weekly transfers of sporangiospores on 
young cv. Ky 14 tobacco plants. Prior to inoculations, 
sporangiospores on sporulating leaves Were Washed off in 
distilled Water, Washed three times With distilled Water, and 
collected on 3.0 pm membranes. Sporangiospores Were then 
resuspended in distilled Water and the concentration Was 
adjusted to 20><103 spores per mL. Six-Week old plants Were 
inoculated by spraying a uniform ?ne mist of the spore 
suspension on the upper surfaces of leaves. The plants Were 
then covered With Wet broWn plastic bags and kept in the 
dark for 16 h. Plants Were then uncovered and placed in a 
groWth chamber. 
In order to assess resistance to R tabacina, the mean 
number of sporangiospores produced per cm2 leaf area Was 
estimated seven days after inoculation. Sporulation Was 
induced by detaching upper leaves from each plant, placing 
them in a large petri dish containing Wet ?lter paper, and the 
dishes Were sealed and alloWed to incubate overnight in a 
groWth chamber. One upper leaf from four individual plants 
per line Was excised for a total of four replications per line. 
The folloWing day, sporulating tissue samples 
(approximately 2—3 cm2) Were excised, measured, and 
placed in tubes containing 10 mL of distilled Water. Tubes 
With tissue samples Were gently vortexed to detach sporan 
giospores from sporangiophores. The concentration of spo 
rangiospores in these suspensions Was estimated using a 
hemacytometer and the total number of sporangiospores in 
the solution Was calculated. The total number of sporan 
giospores Was then divided by the measured leaf area to 
obtain the number of sporangiospores produced per cm2 of 
leaf area. 
Example 10 
RNA Preparation and Northern Blot Analysis 
Total RNA Was isolated from the upper leaves (in case of 
A11 line, only leaves Without lesion Were taken) of 7 to 8 
Week old plants, using Promega (Madison, Wis.) RNAgents 
total RNA Isolation KitTM. Equal amounts total RNA (10 
mg) Were separated on a 1.2% agarose gel, transferred to 
Immobilon N (Millipore, Bedford, Mass.), and hybridiZed 
With 32P-labeled PR-1b (24) DNA probe, and Washed using 
standard protocols (15). These blots Were visualiZed by 
autoradiography. 
RESULTS 
Recombinant DNA Manipulations and Plant 
Transformations 
The coding sequence for the yeast PAB1 gene Was tai 
lored for expression in plants using appropriately designed 
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oligonucleotides and subcloned, as a PCR product, into 
pBluescript. A resulting recombinant Was sequenced in its 
entirety to assure the absence of possible PCR-derived 
changes in the PAB1 sequence. The PAB1 gene Was then 
cloned from this plasmid as an NcoI-SstI fragment into 
pKYLX71-35S2, a plant expression vector designed for use 
withAgrobacterium tumefaciens in transforming plants (11). 
The resulting plasmid (pKYLX71-35S2: yPAB1; see FIG. 1) 
Was mobiliZed from E. coli into Agrobacterium tumefaciens 
and the trans-conjugant Agrobacterium used to transform 
tobacco (12). For comparative purposes, callus and plant 
lines Were also generated using a transformation vector 
containing a cat gene in place ofthe PAB1 gene (13). 
Initially, four plants, derived from tWo independent callus 
cultures, Were regenerated. HoWever, all four of these failed 
to thrive (see beloW) and eventually died. In light of this, 21 
additional independent callus lines Were produced, and 
several plants regenerated from each callus line. With the 
exception of plants from one callus line, all of these plants 
survived, Were fertile, and yielded seed upon self 
fertiliZation. Plants from the other callus line greW very 
sloWly and died after about tWo months. 
Additionally, selected PAB1 callus lines Were maintained 
in culture for an extended period (9 months). These different 
cultures Were indistinguishable in terms of callus morphol 
ogy or vigor of groWth. 
Transgenic Plants that Express the Yeast PAB1 
Gene are Impaired in GroWth 
Many of the plants regenerated from transformed callus 
cultures possessed a range of characteristic groWth defects. 
Plants from callus lines A1, B1, and F6 Were severely 
impaired (an example of a plant from callus line F6 is shoWn 
in FIG. 2, plant A) and developed large necrotic areas on 
most leaves. Plants from lines A11, A18, and F5 displayed 
more vigorous groWth, but developed necrotic lesions on 
older leaves (a plant from line All is shoWn in FIG. 2, plant 
B, and an example of the necrotic lesions that appeared in 
these plants is illustrated in FIG. 3). Plants regenerated from 
callus lines A2, A10, C1, D2, E1, and E2 displayed near 
normal groWth (a plant from line E2 is shoWn in FIG. 2, 
plant C). HoWever, these plants possessed chlorotic sectors 
(the center leaf in FIG. 3) on most leaves. Of the 19 callus 
lines regenerated, nine (lines B2, D1, D3, D4, D5, E3, E5, 
and F2) yielded plants that displayed no visible groWth 
aberration. 
Because of the variability in the appearances betWeen 
plants derived from different callus lines, the levels of the 
yPAB in several different lines Were evaluated by immuno 
blot analysis using a monoclonal antibody speci?c for the 
yPAB (obtained from Dr. Maurice SWanson, University of 
Florida). When this Was done, yPAB Was detected in plants 
that exhibited groWth impairments. In these Western blots, 
proteins Were extracted from primary transformants, sepa 
rated by SDS-PAGE, transferred to nitrocellulose ?lters and 
probed With the aforementioned monoclonal antibodies 
(data not shoWn). In addition to the appropriately siZed 
yPAB, a series of loWer molecular Weight bands Was also 
recogniZed by this antibody. These smaller polypeptides 
may represent breakdoWn products of the yPAB that arise in 
planta, as our extraction procedure is designed to minimiZe 
protease activity after cell breakage. 
An excellent correlation Was seen betWeen plants that 
exhibited a novel phenotype (those from lines A2, A10, A18, 
B1, C1, D2, and F5) and the presence of the yPAB (data not 
shoWn). This correlation extended to the quantitative level; 
10 
15 
20 
30 
35 
40 
45 
55 
60 
65 
10 
plants With the more severe groWth impairment (from callus 
lines A18, B1, D2, and F5) possessed signi?cantly more 
yPAB than did plants With a mild phenotype (from lines A2, 
A10, and C1). In addition, none of the plants that lacked a 
groWth phenotype (from lines B2, D1, E1, E3, E5, and F2) 
contained detectable yPAB. 
These data strongly suggest that the expression of the 
yeast PAB1 gene in tobacco leads to a dramatic groWth 
impairment. This phenomenon is a heritable one; 
kanamycin-resistant F1 plants derived from several 
impaired lines displayed the same groWth impairment as is 
seen in the primary transformants (Table 3). Importantly, 
parents that had severe impairments yielded progeny With 
similar impairments, and those With mild impairments pro 
duced F1 progeny With a mild phenotype as Well (data not 
shoWn). For tWo of these lines (A18 and E1), 100% of the 
kanamycin-resistant progeny Were impaired. HoWever, most 
lines yielded progeny in Which the groWth impairment 
segregated. In some of these lines (e.g., A10, A11, and E2), 
this segregation probably re?ected plant-to-plant variability 
in yPAB levels, as all of the kanamycin resistant progeny 
possessed detectable yPAB. HoWever, in one line (A2), 
detectable expression of the yPAB segregated as Well. 
Finally, in the one “normal” line examined (D5), a small 
percentage of F1 progeny possessed detectable yPAB, indi 
cating that the transgene(s) Was functional in this line, but 
Was not sufficiently active to produce yPAB in quantities 
needed to observe a groWth impairment. 
The above observations indicate that the expression of the 
yeast PAB1 gene in tobacco can cause a dramatic impair 
ment of groWth of the transgenic plants. This effect could be 
caused by any of a number of effects, ranging from an effect 
on the expression of the tobacco PAB gene family to 
interruptions of speci?c PAB functions. To evaluate the 
possibility that the expression of the tobacco PAB gene 
family Was altered in the PAB1 transgenic plants, the levels 
of the tobacco PAB (tPAB) in PAB1 transgenic lines that 
displayed severe (A1, A11) or mild (E2) groWth impair 
ments Were measured by immunoblot analysis. In these 
Western blots, proteins from the transformed plants Were 
extracted, separated by SDS-PAGE, transferred to nitrocel 
lulose ?lters and probed With monoclonal antibodies against 
yPAB or polyclonal antibodies against pea PAB (data not 
shoWn). As in the aforementioned study, the levels of the 
yeast PAB in these lines re?ected the degree of groWth 
impairment; in particular, the yPAB levels in the E2 line 
Were about 30 times loWer than those in the A1 and A11 lines 
(data not shoWn). HoWever, tPAB levels Were similar in all 
of these lines, and Were comparable to tPAB levels in 
“normal” PAB1-transformed lines or in transgenic controls. 
(The differences in tPAB levels betWeen the different lines 
are not reproducible; in other experiments, plants from 
callus lines A1 and All are seen to have similar, or some 
What higher, levels of tPAB.) From experiments such as 
these, it Was clear that the tPAB levels Were unchanged in 
PAB1 transgenic lines that displayed severe groWth impair 
ments. 
A second possible effect of the yPAB in transgenic plants 
may be to interfere With the tPAB function as a consequence 
of being present in a large molar excess. HoWever, immu 
noprecipitation analysis indicated that yPAB levels Were less 
than 20% of tPAB levels (data not shoWn), indicating that 
there is no large molar excess of yPAB in the most impaired 
transgenic lines. 
A third possible effect of the yPAB in transgenic plants 
may be to interfere With the process of poly(A) shortening. 
To test this possibility, poly(A) lengths in total RNA isolated 
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from severe (A11), mild (E2) and normal (D3) PABl 
transformed plants Were determined and compared With 
controls. For this, RNA from six different plants (tWo 
controls, tWo severely impaired plants, one mildly impaired 
plant, and one PABl plant devoid of visible impairment) 
Was labeled With poly(A) polymerase and [a-32P]3‘-dAT P, 
the labeled molecules Were digested With RNAse A (Which 
Will not digest potyadenylate tracts), and the RNAse 
resistant fragments Were examined on a 6% sequencing gel. 
This experiment revealed no obvious differences in poly(A) 
lengths in the different lines; in the six samples shoWn, 
poly(A) lengths extended from <40 to >500 nts, and no 
discernible change in the relative abundance of smaller or 
larger molecules Was observed in the severe or mild lines 
With respect to the controls or normal PABl transformants. 
Expression of the Yeast PABl Gene does not Affect 
Callus GroWth 
As mentioned above, obvious differences betWeen the 
independent callus lines that Were produced Were never 
apparent. This suggested that, although the expression of the 
yeast PABl gene impaired the groWth and development of 
plants, the expression of the same gene had little effect on 
undifferentiated cells. To explore this, yPAB levels in three 
lines that had been maintained for more than six months With 
a transformed control callus culture (of similar age) Were 
compared; these Were qualitatively identical in terms of 
callus morphology, groWth vigor, and regeneration potential. 
One of these callus cultures (All) was that used to regen 
erate plant line All, a line noted above as having a severe 
groWth impairment (FIG. 2) and relatively high yPAB levels 
(data not shoWn). As before, proteins Were extracted, sepa 
rated by SDS-PAGE, transferred to nitrocellulose ?lters, and 
probed With monoclonal antibodies against yPAB. These 
studies indicated that there Was a broad range of yPAB in the 
different lines. Importantly, lines With yPAB levels greater 
than those seen in the A11 line Were identi?ed. Additional 
studies such as this revealed that lines that yielded plants 
With a mild groWth impairment accumulated little yPAB, 
Whereas lines With high levels gave rise to plants With severe 
impairments (data not shoWn). This study indicates that the 
yPAB gene is in fact expressed in undifferentiated plant 
cells, and that high levels of the yPAB do not signi?cantly 
impair the groWth of such cells. 
Plants that Express the Yeast PABl Gene are 
Induced for Systemic Acquired Resistance 
Plants that express the yeast PABl gene at elevated levels 
(e.g., A1 and A11) display characteristics (progressive chlo 
rosis and necrotic lesions) suggestive of possible constitu 
tive defense or hypersensitive responses, in turn leading to 
the possibility that such plants might, at a stage in their 
groWth, possess elevated levels of defense-related gene 
expression and resistance to various pathogens. 
Accordingly, one such line (All) Was evaluated for resis 
tance to a viral pathogen (tobacco mosaic virus), a bacterial 
pathogen (R syringe pv tabaci WF4), and a fungal pathogen 
(Peronospora tabacina Adam), and for expression of a 
defense-related gene (the so-called PRl-b gene; 24). For 
these studies, A11 plants Were selected at a stage of groWth 
at Which “symptoms” characteristic of the pabl-induced 
impairment Were not yet apparent. 
As shoWn in FIG. 4, A11 plants Were signi?cantly resis 
tant to infection by TMV and WF4. While signi?cant lesions 
could be seen on the inoculated controls, they Were virtually 
absent from leaves of A11 plants. This visual assay Was 
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con?rmed, in the case of WF4, by a more quantitative 
bacterial groWth test (FIG. 5). As shoWn in this study, there 
Was no discernible groWth of the bacteria on the A11 leaves 
over the course of this study. In contrast, the bacterial 
population increased by approximately 5 orders of magni 
tude on the control plants. This test indicates that All is 
highly resistant to a bacterial and a viral pathogen, and is 
consistent With the hypothesis that these plants are consti 
tutively induced for systemic acquired resistance 
A11 plants Were also signi?cantly protected against a 
fungal pathogen (R tabacina). This is apparent upon visual 
inspection (not shoWn) and by determining the groWth of the 
fungus. Transgenic cell lines A11 and E2 are compared With 
a control and the results are given in Table 4, With the mean 
of four replications+/—standard error reported per line. This 
study again supports the hypothesis that these transgenic 
plants are induced for SAR. 
TABLE 4 
Mean no. sporangiospores 
Line per cm2 of leaf area (x103) 
Control 92.25 +/— 32.6 
E2 39.00 +/— 14.3 
A11 15.10 +/— 12.2 
As another test of this hypothesis, the expression of a 
pathogenesis-related gene (the PRl-b gene; 24) Was exam 
ined in the transformed control and in line All (Without any 
treatments such as Wounding or inoculation With pathogens). 
In these Northern blot studies, RNA Was isolated from a 
transformed control (GBlB) and the A11 line. The RNA Was 
visualiZed by hybridiZation With a probe speci?c for the 
tobacco PRl-b gene and by staining With ethidium bromide. 
No detectable expression Was observed in the control line. In 
contrast, signi?cant PRl-b expression could be seen in the 
A11 line. This result again supports the hypothesis that SAR 
is induced in a constitutive manner in the A11 line. 
DISCUSSION 
These experiments shoW that expression of the yeast 
PABl gene can impair the groWth of tobacco: a majority of 
independent transgenic plants produced With a yeast PABl 
expression vector displayed a range of characteristic groWth 
abnormalities, and the presence or absence of these abnor 
malities correlated With the presence of detectable yPAB. 
Moreover, the groWth impairment Was heritable and pre 
dictable; primary transformants With severe impairments 
yielded F1 progeny and transformants With mild impair 
ments produced F1 progeny that Were correspondingly 
mildly impaired. 
A signi?cant number of the transgenic lines displayed no 
groWth impairment, and they did not accumulate detectable 
yPAB. HoWever, one such line yielded F1 progeny in Which 
yPAB could be detected (Table 3). This suggests that the 
range of effects, be they visible phenotype or yPAB expres 
sion levels, are a consequence of plant-to-plant variability in 
the activity of the yPAB transgene. More speci?cally, this 
observation indicates that insuf?cient expression, and not an 
inadvertent inactivation of the transgene, is responsible for 
the occurrence of unimpaired plants. 
Transgenic plants that express the yeast PABl gene 
contain a number of probable breakdoWn products that are 
derived from the full siZed yPAB. The relative quantities of 
these mirror those of the native yPAB in the different lines, 
and it is possible that the groWth impairment We observe is 
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caused by the presence of one or more breakdown products, 
and not the full siZed yPAB. These possibilities cannot be 
distinguished at this time, but the possible involvement of 
less than full-length molecules in the impairment may 
provide a useful tool for dissecting structure-function rela 
tionships of PABs in plants. 
These studies rule out a number of possible mechanisms 
for the impairment of growth by the yPAB. The expression 
of the yeast PAB1 gene does not dramatically suppress 
expression of the corresponding tobacco genes, as has been 
seen in other instances of heterologous gene expression in 
plants (14). However, it has been established that Arabidop 
sis contains several PAB genes, each expressed in different 
tissues and at different times during development (6,10). It 
is likely that tobacco also contains more than one PAB gene. 
Thus, it is possible that the yeast PAB1 gene may exert its 
effects through a differential interference of expression of a 
subset of tobacco PAB genes, and that this effect may not be 
apparent due to possible differential recognition of tobacco 
PABs by the antibodies raised against the pea PAB. Such a 
scenario merits mention as it implies vital roles for different 
PABs in vegetative growth and development in tobacco. 
Immunoprecipitation analyses indicate that the yPAB 
levels are less than 20% of those of the tPAB (data not 
shown), indicating that the effects of the yeast PAB1 gene 
are not due to the presence of a large molar excess of this 
protein. Poly(A) lengths are similar in impaired PAB1 plants 
and in unimpaired transgenic or controls, indicating that the 
yPAB does not act by interfering with poly(A) shortening. 
Because callus lines that contain high levels of yPAB are as 
vigorous and long-lived as lines with no detectable yPAB, it 
is inferred that the yPAB does not affect general translation 
in plant cells. However, as implied in the preceding section, 
the effects on poly(A) shortening or translation in special 
iZed cell types cannot be ruled out. Also, the possibility that 
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link between yPAB expression and SAR (and the growth 
impairment) is not clear, but the possibility that cytoplasmic 
RNA metabolism may affect defense responses is interest 
ing. In any case, future studies with this system should lead 
to new and important insight into the functions of PABs and 
RNA metabolism in plants, and as well into the means by 
which SAR might be triggered. 
The present invention has been described with reference 
to certain examples, which illustrate various aspects of the 
invention. It should be appreciated, however, that modi? 
cations and improvements to these examples can be prac 
ticed within the scope of the appended claims and their 
equivalents. 
TABLE 1 
Bacterial Plant Pathogens 
Genus Disease 
Erwinia Fireblight, Stewarts’ Wilt, Slime Flux, Bacterial 
Soft Rot 
Clavibacter Potato Ring Rot, Alfalfa Bacterial Wilt 
Corynebacterium Wheat Bacterial Spike Blight 
Pseudomonas Bacterial Blight, Halo Blight of Beans and Oats, Basal 
Glume Rot and Bacterial Leaf Blight of Wheat 
Xanthomonas Bacterial Black Chaff and Bacterial Stripe of Wheat, 
Bacterial Spot of Peach 
TABLE 2 
Genome type 
Viral Plant Pathogens 
Virus 
dsDNA 
ssDNA 
dsRNA 
RNA Viruses with 
Negative-Sense or 
Cauli?ower Mosaic Virus, Badnaviruses 
Geminiviruses 
Plant Reoviruses, Cryptoviruses 
Rhabdoviridae, Tomato Spotted Wilt Virus, Tenuiviruses 
Ambisense Genome 
Positive Sense ssRNA 
Viruses 
Monopartite Genomes: Tobacco Mosaic Virus, Potato Virus 
X, Potyviridae, Closteroviruses, Turnip Yellow Mosaic Virus, 
Tomato Bushy Stunt Virus, Luteoviruses, Sequiviridae 
Bipartite ssRNA: Tobacco Rattle Virus, Cowpea Mosaic 
Virus, Tobacco Ringspot Virus, Pea Enation Mosaic Virus, 
Red Clover Necrotic Mosaic Virus 
Tripartite ssRNA: Brome Mosaic Virus, Cucumber Mosaic 
Virus, Alfalfa Mosaic Virus, Barley Stripe Mosaic Virus, 
Beet Necrotic Yellow Vein Virus 
the yeast PAB accumulates to a great excess over the 
tobacco PAB in speci?c cell types cannot be eliminated. 
The yPAB protein thus impairs the growth of plants by an 
as yet unidenti?ed mechanism. However, the observations 
indicating that lines that express the yeast PAB1 gene 
possess characteristics of SAR suggest that the growth 
impairment may be a manifestation of an induction of a 
hypersensitive response, or of cell death, which is triggered 
by the yPAB protein. Controlled expression of the yPAB 
protein, which represses the deleterious effects of this pro 
tein while providing an SAR, has been demonstrated. The 
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TABLE 3 
Inheritance of the selectable marker and yeast PAB1 genes 
Callus Pheno- % germi- % krnI with % krnI with 
line3 typeb nationC kmI:kmS(d) symptomse yPABf 
A2 Mild 93 91:9 47 67 
A10 Mild 97 96:4 32 100 
A11 Severe 94 72:28 85 100 
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TABLE 3-continued 
Inheritance of the selectable marker and yeast PABl genes 
Callus Pheno- % germi- % kmI with % kmI with 
line3 typeb nationC kmbkmsm) symptomse yPABf 
A18 Severe 97 78:22 100 nd 
C1 Normal 96 98:2 0 nd 
D3 Normal 85 72:28 0 nd 
D4 Normal 89 83:17 0 nd 
D5 Normal 97 77:23 0 11 
E1 Mild 100 74:26 100 nd 
E2 Mild 100 75:25 83 100 
E5 Normal 95 78:22 0 nd 
F2 Normal 93 87:13 0 nd 
F5 Severe 90 83:17 51 nd 
aParental callus line from which the primary transgenic plant used to generate 
these seed lots. 
bDegree of growth impairment; normal — no impairment; mild — plants had 
chlorotic sectors but no obvious necrosis or growth stunting; severe — plants 
had eXtensive necrotic areas and were stunted in their growth. 
CPercent of seeds that germinated on media containing kanamycin. 
dPercent of kanamycin resistant and sensitive individuals determined by 
germination on kanamycin-containing media. 
8The percent of kanamycin-resistant plants that displayed an impairment after 
siX weeks growth (a minimum of 50 plants were scored for each test). 
fThe percentage of kanamycin-resistant plants that possessed detectable 
yPAB as determined by immunoblot analysis (a minimum of ten plants were 
scored for each test). 
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What is claimed is: 
1. A method of enhancing resistance of a plant to a 
bacterial, fungal or viral pathogen comprising: 
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transforming the plant with a polynucleotide encoding a 
yeast polyadenylate binding (yPAB) protein; and 
maintaining the plant, wherein the yPAB protein is 
expressed and the plant has enhanced resistance to a 
bacterial, fungal or viral pathogen as compared to an 
untransformed plant. 
2. The method of claim 1, wherein said transforming is 
performed on a callus culture or leaf eXplants, and the plant 
is regenerated from said callus culture or leaf eXplants. 
3. The method of claim 1, wherein said transforming is 
performed with an Agrobacterium vector. 
4. The method of claim 1, wherein the polynucleotide 
comprises a CaMV promoter, which regulates expression of 
the yPAB protein. 
5. The method of claim 4, wherein the CaMV promoter is 
the 35S2 promoter. 
6. The method of claim 1, wherein the yPAB protein is 
yPAB1. 
7. The method of claim 1, wherein the plant is selected 
from the group consisting of corn, rice, wheat, maize, 
alfalfa, oats, barley, rye, sorghum, clover, tobacco, tomato, 
pea, potato, cauli?ower, beans, cucumber, beet, turnip, 
spinach, kale, cabbage, squash, melon, cotton, apple, peach, 
and plum. 
8. The method of claim 1, wherein the bacterial pathogen 
is from a genus selected from the group consisting of 
Erwinia, Clavibacter, Corynebacterium, Pseudomonas, and 
Xanthomonas. 
9. The method of claim 1, wherein the ?ngal pathogen is 
selected from the group consisting of Ascomycetes, 
Basidiomycetes, Zygomycetes, Oomycetes, 
Deuteromycetes, Peronosporomycetes, Chytridiomycota, 
Zygomycota, Plectomycetes, Loculoascomycetes, 
Discomycetes, Pyrenomycetes, Heterobasidiomycetes, 
Homobasidiomycetes, Teliomycetes, Ustomycetes, 
Septomycetes, Saprolegniomycetidae, and Plasmodio 
phorida. 
10. The method of claim 1, wherein the viral pathogen is 
a cytoplasmic plant virus. 
11. The method of claim 1, wherein the viral pathogen is 
selected from the group consisting of cauli?ower mosaic 
virus, badnaviruses, geminiviruses, reoviruses, 
cryptoviruses, rhabdoviridae, tomato spotted wilt virus, 
tenuiviruses, tobacco mosaic virus, potato virus X, 
potyviridae, closteroviruses, turnip yellow mosaic virus, 
tomato bushy stunt virus, luteoviruses, sequiviridae, tobacco 
rattle virus, cowpea mosaic virus, tobacco ringspot virus, 
pea enation mosaic virus, red clover necrotic mosaic virus, 
brome mosaic virus, cucumber mosaic virus, alfalfa mosaic 
virus, barley stripe mosaic virus, and beet necrotic yellow 
vein virus. 
12. The method of claim 1, wherein said resistance is 
inheritable. 
13. The method of claim 1, wherein a pathogen resistance 
(PR) gene is activated concurrent with the resistance to a 
bacterial, fungal or viral pathogen. 
14. Aplant transformed with a polynucleotide comprising 
a nucleotide sequence encoding a yPAB protein. 
15. The plant of claim 14, wherein the yPAB protein is 
yPAB1. 
16. The plant of claim 14, wherein the polynucleotide 
comprises a CaMV promoter operably linked to the nucle 
otide sequence encoding a yPAB protein. 
17. The plant of claim 16, wherein the CaMV promoter is 
the 35S2 promoter. 
18. The plant of claim 14, which has enhanced resistance 
to a bacterial, fungal or viral pathogen relative to a plant not 
transformed with said polynucleotide. 
19. The plant of claim 14, which is selected from the 
group consisting of corn, rice, wheat, maize, alfalfa, oats, 
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barley, rye, sorghum, clover, tobacco, tomato, pea, potato, 20. A callus culture or leaf eXplant transformed With a 
cauli?ower, beans, cucurnber, beet, turnip, spinach, kale, polynucleotide that encodes a yeast PAB protein‘ 
cabbage, squash, rnelon, cotton, apple, peach, and plum. * * * * * 
